United States · FDA National Drug Code directory
Buprenorphine and Naloxone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0228-3154_f8429e6b-f73d-4f29-8e2e-f8910cfba41d
- Product NDC
- 0228-3154
- Form
- TABLET
- Composition / generic term
- Buprenorphine and Naloxone
- Labeler
- Actavis Pharma, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20130304
- Source listing expiry
- 20271231
Source-listed ingredients
- BUPRENORPHINE HYDROCHLORIDE — 2 mg/1
- NALOXONE HYDROCHLORIDE DIHYDRATE — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (0228-3154-03) · 0228-3154-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →